ARBS — Arterra Bioscience SpA Cashflow Statement
0.000.00%
Last trade - 00:00- €14.58m
- €10.90m
- €3.30m
- 76
- 61
- 77
- 85
Annual cashflow statement for Arterra Bioscience SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 0.857 | 1.11 | 1.11 | 1.41 | — |
| Depreciation | |||||
| Non-Cash Items | -0.044 | 0.111 | 0.105 | 0.729 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.625 | -1.14 | -0.306 | -1.28 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.73 | 0.48 | 1.4 | 1.4 | — |
| Capital Expenditures | -1.61 | -0.383 | -1.11 | -1.73 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.01 | — | — | 0.04 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -1.6 | -0.383 | -1.11 | -1.69 | — |
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.8 | -0.23 | -0.014 | -0.125 | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.94 | -0.133 | 0.278 | -0.421 | — |